Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VPS33A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | RRS1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | MRPL10 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | PLEKHG4B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CMTM2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | E2F1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | MT3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | HACE1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CLCN2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | SLC26A10 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |